Skip to main content
Premium Trial:

Request an Annual Quote

Products & Services: Mar 26, 2009


Pharma IQ will hold a conference next month on the use of oligonucleotides in drug development.

The event will include, among others, sessions on vector-derived RNAi as tools and therapeutics; gene silencing by the gymnotic delivery of oligos; microRNA silencing; and use of miRNAs as biomarkers.

Details about the conference can be found here.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.